All Articles

A tragic suicide has exposed the dark side of AI companionship, sparking a veteran's mission to address a crisis of faith, mental health, and connection.

With profits rebounding and a major acquisition secured, GTPL Hathway's Q1 results signal a bold new phase of strategic expansion and technological ambition.

Korn Ferry's top RPO ranking isn't just a press release. It signals a market shift where AI, integrated consulting, and strategic foresight are the new table stakes.

With the hire of ANZ's former financial crime head, FTI Consulting is doubling down on a market facing intense regulatory pressure and evolving AI threats.

ASP Isotopes is cleaning house with a major debt-for-equity swap. It's more than accounting—it's a bold move to unleash a key player in the future of nuclear energy.

A landmark Chinatown asset returns to market with a S$10M price cut, testing investor appetite for heritage properties in a shifting economic landscape.

Great Southern Bancorp's Q2 earnings dip due to strategic cuts, but a closer look reveals a bank fortifying itself against industry headwinds.

A groundbreaking NEJM report shows Neutrolis's therapy rapidly reversed severe Lupus symptoms, validating a new, non-immunosuppressive approach.

A new partnership between Flexzo Ai and Maiden Lane Medical signals a major shift, using AI not just for efficiency but as a cure for the clinician shortage.

Infinity Natural Resources adds M&A architect Timothy Dugan to its board, a move analysts see as a clear signal of the shale driller's growth ambitions.

The cord blood pioneer reported a 56% profit surge despite a revenue dip. But a key dispute with Duke University has halted its ambitious expansion into therapy.

Despite currency headwinds, Karooooo posted record subscriber growth. Our analysis unpacks the operational strategy turning investment into market dominance.

Matson posts stellar Q2 results fueled by its China service, but a closer look reveals a complex picture with weaker domestic volumes and shifting logistics.

With a new NYSE ticker and a combined portfolio of Mexican gold assets, the merger of Goldgroup and GRC creates a significant new player for investors.

As EverQuote prepares its Q2 2026 report, the market watches closely. Will its AI-powered growth engine justify its ambitious vision for the P&C sector?

As Applied Digital prepares its year-end report, all eyes are on the data center builder. Can it sustain its explosive growth and justify its massive bets on AI?

As Celldex nears pivotal data for its lead drug, the planned retirement of its long-serving CFO marks a strategic pivot toward becoming a commercial powerhouse.

The firm reported a Q4 loss but a record $111M backlog fuels its ambitious plan for $150M revenue and a pivot to high-growth quantum and defense markets.

Parse Biosciences, QIAGEN's strategic acquisition, just partnered with Australia's Garvan Institute. It's more than science—it's a calculated play to win.

A new deal between biosolutions giant Novonesis and innovator TurtleTree aims to mass-produce a vital milk protein, signaling a tectonic shift for the nutrition industry.